SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mulanoon2007 who wrote (4037)12/12/2015 8:34:01 PM
From: tktom  Read Replies (1) of 4474
 
Not a rumbling but in the post ASCO Alice Shaw interview with Tony Mok she said the pulmonary tox of BRIG "makes me a little bit nervous...". See the vimeo interview vimeo.com/140680817 at about 6 minutes.
That would be the death knell of the company if there is pulmonary tox with Brignatinib. It seems to me that that has already been vetted by now. Might explain why there is no interest in Ariad at this late stage of the game though..
Anecdotally, however, there is good uptake with patients on Brignatinib.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News